Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects.
Whilst it has been postulated that atrial natriuretic peptide (ANP) may modulate pituitary hormone release, several investigations in non-human species have reported conflicting results when looking for an effect on the hypothalamo-pituitary-adrenal axis. However, in a recent study significant inhib...
Main Authors: | Ur, E, Faria, M, Tsagarakis, S, Anderson, J, Besser, G, Grossman, A |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
1991
|
Podobne knjige/članki
-
Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro.
od: Ibanez-Santos, J, et al.
Izdano: (1990) -
Involvement of calmodulin in depolarization-induced release of corticotrophin-releasing hormone-41 from the rat hypothalamus in vitro.
od: Tsagarakis, S, et al.
Izdano: (1991) -
Isolated ACTH deficiency with absent response to corticotrophin-releasing factor--41. Evidence for a primary pituitary defect.
od: Murch, S, et al.
Izdano: (1991) -
The cortisol response to corticotrophin-releasing factor is blunted in obesity.
od: Kopelman, P, et al.
Izdano: (1988) -
Gamma-Aminobutyric Acid Modulation of Corticotrophin-Releasing Factor-41 Secretion from the Rat Hypothalamus in vitro.
od: Tsagarakis, S, et al.
Izdano: (1990)